文献速递主动脉疾病

医师自制牛心包管状移植物治疗主动脉感染:一项欧洲多中心研究

Physician Made Bovine Pericardial Tube Grafts in Aortic Infection: A European Multicentre Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-02-08

这项回顾性与前瞻性国际多中心研究分析了2008年1月至2020年12月四家欧洲三级转诊中心收治的168例(77%男性,平均年龄67±11岁)因自体主动脉感染或主动脉移植物感染行原位重建并采用医师自制牛心包管状移植物的患者。30天死亡率为15%,中位随访26个月,5年估计生存率为50%,自体感染组优于移植物感染组(69% vs 44%,p=.011);再感染率低,移植物并发症少。

要点

  • 30天总死亡率为15%,自体感染组11%、主动脉移植物感染组17%(p=.45)。
  • 5年估计生存率自体感染组69% vs 移植物感染组44%(p=.011)。
  • 预计1、2、3、5年免于再感染率分别为94%、92%、90%、86%。

核心结论

  • 本多中心研究显示,使用医师自制牛心包管状移植物时再感染率低,与其他生物移植物相当。
  • 移植物并发症(主要为吻合口动脉瘤和狭窄)发生率低,未出现移植物退变。
  • 医师自制牛心包管状移植物是自体主动脉感染或主动脉移植物感染中原位重建的优秀工具。

研究设计与样本

  • 本研究为回顾性与前瞻性国际多中心研究,纳入2008年1月至2020年12月四家欧洲三级转诊中心因自体感染或移植物感染行原位主动脉重建并采用医师自制牛心包管状移植物的患者。
  • 共纳入168例患者(77%男性,平均年龄67±11岁),其中自体主动脉感染38例(23%)、主动脉移植物感染130例(77%)。
  • 主要终点为再发主动脉感染;次要终点为持续性感染、因感染行主动脉再手术、移植物相关并发症和死亡。

主要发现

  • 30天死亡率总体为15%(n=26),自体感染组为11%(n=4),主动脉移植物感染组为17%(n=22),p=.45。
  • 中位随访26个月(四分位距[IQR]10,51);1、2、3、5年估计生存率分别为64%、60%、57%、50%,自体感染组(81%、77%、77%、69%)显著优于移植物感染组(58%、55%、51%、44%;p=.011)。
  • 9例(5.3%)出现持续性感染,10例(6%)在中位10个月(IQR 5,22)后再发主动脉感染,1、2、3、5年估计免于再感染率分别为94%、92%、90%、86%。
  • 1、2、3、5年估计免于移植物并发症率分别为91%、89%、87%、87%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study examines outcome and durability of physician made bovine pericardial tube grafts in aortic infections in all anatomical locations. METHODS: This was a retrospective and prospective international multicentre study. Peri-operative and long term outcomes of patients undergoing in situ aortic reconstruction for native or graft infections with physician made bovine pericardial tube grafts between January 2008 and December 2020 in four European tertiary referral centres were analysed. The primary endpoint was recurrent aortic infection. Secondary endpoints were persistent infection, aortic re-operation for infection, graft related complications, and death. RESULTS: One hundred and sixty eight patients (77% male, mean age 67 ± 11 years) were identified: 38 (23%) with native and 130 (77%) with aortic graft infection. The thirty day mortality rate was 15% (n = 26) overall, 11% (n = 4), and 17% (n = 22) for native and aortic graft infections, respectively (p = .45). Median follow up was 26 months (interquartile range [IQR] 10, 51). Estimated survival at one, two, three, and five years was 64%, 60%, 57%, and 50%, and significantly better for native (81%, 77%, 77%, and 69%) than for graft infections (58%, 55%, 51%, and 44%; p = .011). Nine patients (5.3%) had persistent infection and 10 patients (6%) had aortic re-infection after a median of 10 months (IQR 5, 22), resulting in an estimated freedom from re-infection at one, two, three, and five years of 94%, 92%, 90%, and 86%. Estimated freedom from graft complications at one, two, three, and five years was 91%, 89%, 87%, and 87%. CONCLUSION: This multicentre study demonstrates low re-infection rates when using physician made bovine pericardial tube grafts, comparable to those of other biological grafts. The rate of graft complications, mainly anastomotic aneurysms and stenoses, was low, while graft degeneration was absent. Physician made bovine pericardial tube grafts are an excellent tool for in situ reconstruction in the setting of native aortic infection or aortic graft infection.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Weiss S, Hugas Mallorqui M, Czerny M, et al. Physician Made Bovine Pericardial Tube Grafts in Aortic Infection: A European Multicentre Study. Eur J Vasc Endovasc Surg. 2024. PMID: 38341175. doi:10.1016/j.ejvs.2024.02.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。